Rainbow at shoreline

The Massachusetts ME/CFS & FM Association, a 501(c)3 founded in 1985, exists to meet the needs of patients with ME (Myalgic Encephalomyelitis), CFS (Chronic Fatigue Syndrome) or FM (Fibromyalgia), their families and loved ones. The Massachusetts ME/CFS & FM Association works to educate health-care providers and the general public regarding these severely-disabling physical illnesses. We also support patients and their families and advocate for more effective treatment and research.

Summary of 8th Invest in ME Intl. ME Conf. 2013

Mainstreaming ME Research: The 8th Invest in ME International ME Conference 2013 (Phoenix Rising) This is an excellent summary by Mark Berry on the 8th Invest in ME International ME Conference (IIMEC8) held May 31, 2013 in London, UK. The conference titled, "Mainstreaming ME Research: Infections, Immunity and Myalgic Encephalomyelitis," featured clinical and research updates as well as frank discussion by more than a dozen international physicians and scientists about the need for new diagnostics and biomarkers. 

Conference speakers represented Australia, Germany, Norway, the United Kingdom and four researchers from the United States: Drs. Daniel Peterson with the Simmaron Research Foundation in Incline Village, NV; Andreas Kogelnik with the Open Medicine Institute in Mountain View, CA; Mady Hornig with the Center for Infection and Immunity (CII) at the Columbia University Mailman School of Public Health, New York, NY and Rakib Rayhan with the Chronic Pain and Fatigue Research Center, Georgetown University Medical Center in Washington, D.C.

Conference Highlights (taken directly from the report) describe key messages discussed by each speaker:

  • Dr Ian Gibson announces new PhD studentship in Norwich looking at gut bacteria. "Things are beginning to pop, across the nation and across the world...There's a new spirit loose, I think, in the ME field".
  • Dr Peterson keynote: "It's time to stop querying patients and begin developing new diagnostics". We need both clear endpoints and clear populations for successful research.
  • Dr Kogelnik: Medicine is at a crossroads, and ME will be "key disease" in coming "health/disease revolution": technology enables the 'Quantified Self' and personalized medicine. Govt agencies "not the enemy", it's "their ignorance and our lack of data" —our job is to bring them the data so it can't be ignored.
  • Dr Rakib Rayhan: In Gulf War Illness, Baraniuk et al believe their brain scans after exercise challenge produced a "quite robust biomarker", and they want to extend to ME/CFS. New study out in a couple of weeks finds 2 subgroups for pain and fatigue post-exercise.
  • Professor Greg Towers puts XMRV saga to bed: valuable lessons learned mean this kind of situation should never happen again.
  • Professor Mady Hornig: Final analysis of cerebrospinal fluid now underway; possible finding of 'different patterns of cytokine associative networks' and 'potential novel candidate' in CSF still needs to be confirmed.
  • Dr Clare Gerada steps into the lions' den and "tells it straight"—attempts to "build a bridge between the largest Royal College and a very important problem"—hopes to "be better able to work with you to improve the care you receive from my profession".
  • Dr Donald Staines stands in for Professor Sonya Marshall-Gradisnik. Publications expected in next weeks and months; still finding "sustained, demonstrable, significant impairment in NK cell function", "highly confident" of up-regulation of T-reg cells; "clear derangement in the immune system...it's irrefutable", and "anyone who suggests that this might be fixed by exercise therapy should probably be de-registered I think".
  • Dr Amolak Bansal senses a "paradigm shift" towards model of subtle form of autoimmunity in ME; suspects patients' B cells are failing to mature properly and producing low avidity antibodies; lasting response to B-cell depletion therapy may require clearing the viruses responsible in addition to 'rebooting' the B cells.
  • Norwegian ME Association presents awards to Invest in ME founders Richard and Pia Simpson, and to Professor Malcolm Hooper for "untiring and exceptional contribution to the ME cause". Hooper accepts with his shortest ever speech.
  • Carmen Scheibenbogen and her team at Charite are finding similar immune dysfunction and share many of the same theories as Bansal, Fluge and Mella. They're trying to develop a diagnostic test, investigating EBV infections in depth, and seeing 3 immune subtypes of CFS. Hoping for solid data in about 6 months.
  • Professor Mella and Dr Fluge are closing in on publication of their follow-up study on Rituximab therapy.


The above excerpt is posted with permission from Mark Berry, Board Member and writer for Phoenix Rising.

Meet the Author, Erica Verrillo, an Inspiring and Engaging Event

 

ericaverrillorogerkingphotowebThe Massachusetts CFIDS/ME & FM Association enthusiastically welcomed Erica Verrillo, author of Chronic Fatigue Syndrome: A Treatment Guide, 2nd Edition (Amazon Digital Services, Inc, 2012) on Saturday, May 18, 2013, in Sturbridge, MA. Guests came from far corners of the state, as well as some nearby states, to meet and hear Ms. Verrillo whose book is praised by patients and many specialists as the "go-to-reference" for CFS. The author noted she used the name Chronic Fatigue Syndrome (CFS) in this second edition because CFS is currently the most widely utilized term by clinicians and researchers in the United States. She also clarified the information in the book reflects many years of extensive research and not personal preferences or opinions.

Jane Shiyah, a parent of an adult child affected by CFS, provided a most gracious introduction for Erica Verrillo, describing her as "complex, complicated and multifaceted" as the illness itself. She shared some of Ms. Verrillo's fascinating and wide-ranging accomplishments such as being a classical musician, traveling and learning first-hand about the culture and political issues in Latin America as a hitchhiker, becoming a Mayan linguist, founding an aid organization for Guatemalan refugees, and having a long history as a political activist. Verrillo has also written many short stories and a series of middle-reader fantasies—a trilogy about Elissa, a teen who lives in a magical place and can speak to the animals. These stories were invented by Ms. Verrillo for her daughter who also has CFS.

Erica Verrillo explained how this book came about (referring to the first edition published in 1998 by St. Martin's Press). Although she had fallen ill in 1987, that problem was never diagnosed. In 1992, while working towards her doctorate in Speech Communication at the University of Texas in Austin, Ms. Verrillo became sick again upon her return from field work in Guatemala. This time she was extremely ill, was forced to abandon her studies, had to be hospitalized, and was confined to her bed for two years. Her daughter also become very ill during the same time. They both were diagnosed with CFS. (Ms. Verrillo was diagnosed by Dr. Paul Cheney.)

Like most patients, Ms. Verrillo was shocked to discover how little doctors knew about CFS—having seen her two year struggle be described as "spells" in her medical records. She was also surprised to find nothing published on treatments for CFS. Having studied and worked in a variety of fields, Verillo proceeded to do her own research. She became acquainted with Lauren Gellman, a vice-president of a Fortune 500 company prior to developing CFS, who was very ill but shared a mutual concern about this lack of information. Due to the severity of their illness and their personal limits, they communicated with each other through an exchange of cassette tapes that they mailed back and forth. After two years of hard work and true grit, their book was completed and ready for publication. The authors actually thought about what they would do if a cure was found in the interim; they would burn the manuscript! However, their 127,000 word text did not go to waste and served as the most comprehensive treatment guide available to patients and healthcare professionals for many years.

Erica Verrillo read part of the Introduction which describes the premise of the book, "The absence of a cure does not in any way imply there is no treatment for CFIDS." Throughout the ages, many different methods and remedies have been used to care for people—these may provide symptom relief, repair damage, and/or help to restore strength. The purpose of treatment was conveyed in this analogy, "If CFIDS is like falling into a hole, as some patients have observed, recovery is like climbing out of the hole, step by step, rung by rung." Knowledge about effective treatments can provide patients with the rungs leading to recovery. Recovery can vary greatly between patients, can being substantial or partial, but Verrillo thinks recovery is possible at any point based on cases reviewed. [Note: CFIDS is the term used in the first edition.]

The author and the patient community share many frustrations, particularly how the medical community cannot seem to see the forest for the trees. Post-exertional malaise (PEM) is now recognized as the most distinct feature of CFS that is usually not found in other illnesses. PEM is when effort expended on physical or mental activity causes an exacerbation of all symptoms in a person with CFS. The sicker the person is, the less effort it will take to produce PEM. Doctors very rarely, if ever, ask patients whether they have this significant symptom. Doctors tend not to look at the body as an "entire system." Ms. Verrillo stated that the truth is that every illness is a multi-system disorder because the immune, endocrine and nervous system often share the same receptors. She provided many other examples of things that go unnoticed in CFS.

With that said, new research on the causes and mechanisms in CFS and treatment protocols have emerged over the last 15 years warranting a complete update of the first edition of the treatment guide. Ms. Verrillo had to review all previously and newly published research and to decide which material to keep or omit—this was an arduous task, but someone had to do it. The second edition has more than twice the data of the first one, totaling 277,000 words or 817 pages. This shows the depth and scope of Verrillo's research and work.

Erica Verrillo explained that by self-publishing the second edition, it allowed her to give copies of the book away. So far, more than 15,000 copies have been downloaded for free. Ms. Verrillo described this book as a labor of love, created solely to educate patients and the medical community. The information can be downloaded directly to the reader's computer without the need to own a Kindle or Nook, from Amazon for only $2.99. The E-format allowed Verrillo to incorporate links to numerous resources; so everything a patient or a doctor needs is just a click away. This book functions as an encyclopedia on CFS including natural and homeopathic treatments.

We would like to extend our sincere gratitude to Erica Verrillo for sharing her time, wisdom, and valuable contribution with our guests. To learn more about Ms. Verrillo, visit her website.

Patients with Pets

For many people who have cats or dogs, they are like our children. We may share kisses, silverware and our beds. Many pet owners don't think twice about it.

For those who have cats, they are almost forced into keeping their place tidy because cats can get into anything absolutely anywhere. Cat owners know that they don't own the cats, the cats own them.

Household pets or companion animals can boost a person's physical and emotional health and there is research to prove it. Having pets has been shown to lower your blood pressure, (Kingwell BA, et al. "Presence of a pet dog and human cardiovascular responses to mild mental stress." Clin Auton Res. 2001 Oct;11(5):313-7) and help to keep weight down due to the daily exercise of walking the dog.

It has also been proven that owning a pet can decrease mental stress (Allen K, et al. "Pet ownership, but not ace inhibitor therapy, blunts home blood pressure responses to mental stress." Hypertension. 2001 Oct;38(4):815-20) and overall promote a strong pet-human relationship (Friedmann E and Son H. "The human-companion animal bond: how humans benefit." Vet Clin North Am Small Anim Pract. 2009 Mar;39(2):293-326. doi: 10.1016/j.cvsm.2008.10.015.).

Science aside, on a good day, the simple benefits of walking a dog takes you from social isolation and provides opportunities to meet and greet other dog owners—pet ownership enables you to have a pseudo social life. Unlike your counterparts who are home in bed alone, you are never alone. You have to get up to feed the animals—they help to add a routine to your day. No sick days for you even if that means you use your energy to feed the animals—caring for another living creature can make you feel needed and a little less focused on the illness.

However, there are some choices which should be considered. Since we don't know the exact cause of ME/CFS and there is the possibility of a viral implication, be a bit more careful when you are in a relapse. It has been shown in many studies (too many to list) that ME/CFS affects the immune system. In a study that looked at immunocompromised patients and whether having pets posed a potential threat to their health, it was shown that with simple guidelines, the benefits outweighed the risks (Steele RW. "Should immunocompromised patients have pets?" Ochsner J. 2008 Fall;8(3):134-9).

It has not been proven that whatever we have can jump species, but it also hasn't been disproven. We are dealing with an unknown, so be cautious. When disposing of animal waste, wear gloves, wash hands frequently, and watch for infections in your animals.

Ticks in dogs and cats should be removed in a specific way and if in doubt, take the animal to a veterinarian. Ticks can cause Lyme Disease and in humans, if this is not treated properly, then it has the potential of becoming a persistent illness that could affect multiple organs.

Do not share silverware. Do not kiss your pet on the face and mouth, and if possible, don't share the bed. When you are really ill, your pet knows it. They have an uncanny ability to tune into you perhaps more than you tune into them.

So, if they are banned from the bed, they may not be happy but tell them you are protecting them from getting ill. One thing that always holds true about all dogs, no matter the breed, age or size, is that they love us unconditionally, even on our bad days.

Notice about names

The Massachusetts ME/CFS & FM Association would like to clarify the use of the various acronyms for Chronic Fatigue Syndrome (CFS), Chronic Fatigue & Immune Dysfunction Syndrome (CFIDS) and  Myalgic Encephalomyelitis (ME) on this site. When we generate our own articles on the illness, we will refer to it as ME/CFS, the term now generally used in the United States. When we are reporting on someone else’s report, we will use the term they use. The National Institutes of Health (NIH) and other federal agencies, including the CDC, are currently using ME/CFS. 

Massachusetts ME/CFS & FM Association changed its name in July, 2018, to reflect this consensus.